Shopping Cart
Remove All
Your shopping cart is currently empty
Carlumab is a high-affinity human monoclonal antibody that targets CCL2, blocking its interaction with the CCR2 receptor, thereby inhibiting CCL2-mediated tumour growth and suppressing the recruitment of monocytes/macrophages in the tumour microenvironment. It can be used for prostate and breast cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $215 | - | In Stock | |
| 5 mg | $563 | - | In Stock | |
| 10 mg | $896 | - | In Stock |
| Description | Carlumab is a high-affinity human monoclonal antibody that targets CCL2, blocking its interaction with the CCR2 receptor, thereby inhibiting CCL2-mediated tumour growth and suppressing the recruitment of monocytes/macrophages in the tumour microenvironment. It can be used for prostate and breast cancer research. |
| Synonyms | CNTO888, CNTO 888, Anti-CCL2 monoclonal antibody |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | CCL2/MCP1 |
| Molecular Weight | 144.87 kDa |
| Cas No. | 915404-94-3 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.